Literature DB >> 20224020

Training in psychiatric genomics during residency: a new challenge.

Joel G Winner1, Deborah Goebert, Courtenay Matsu, David A Mrazek.   

Abstract

OBJECTIVE: The authors ascertained the amount of training in psychiatric genomics that is provided in North American psychiatric residency programs.
METHODS: A sample of 217 chief residents in psychiatric residency programs in the United States and Canada were identified by e-mail and surveyed to assess their training in psychiatric genetics and genomics.
RESULTS: Eighty chief residents completed the survey for a response rate of 37%. Forty-five respondents (56%) reported that during their residency training they received 3 or fewer hours of training in genomics. Of these, 13 reported that they had received no training in genomics. Chief residents who received 3 or fewer hours of training were more likely to indicate that they had not actively participated in a multidisciplinary team which utilized genetic/genomic specialists than residents who had received more didactic training in genomics (p<0.001). Although 67% of 77 respondents indicated that they understood the concept of genetic predisposition to psychiatric disease, only 14% of 80 respondents indicated that they understood the role a genetic counselor could play on a clinical team.
CONCLUSION: Training in the clinical applications of genomic testing has not been thoroughly implemented in some residency programs.

Entities:  

Mesh:

Year:  2010        PMID: 20224020     DOI: 10.1176/appi.ap.34.2.115

Source DB:  PubMed          Journal:  Acad Psychiatry        ISSN: 1042-9670


  7 in total

Review 1.  Genetic testing in psychiatry: a review of attitudes and beliefs.

Authors:  Ryan E Lawrence; Paul S Appelbaum
Journal:  Psychiatry       Date:  2011       Impact factor: 2.458

Review 2.  Ethics and neuropsychiatric genetics: a review of major issues.

Authors:  Steven K Hoge; Paul S Appelbaum
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-25       Impact factor: 5.176

3.  Evaluating genetic counseling for individuals with schizophrenia in the molecular age.

Authors:  Gregory Costain; Mary Jane Esplen; Brenda Toner; Stephen W Scherer; Wendy S Meschino; Kathleen A Hodgkinson; Anne S Bassett
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

4.  Pharmacogenomics and personalized medicine in neuropsychiatry.

Authors:  Francis J McMahon; Thomas R Insel
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

5.  Facilitating clinical implementation of pharmacogenomics.

Authors:  David A Mrazek; Caryn Lerman
Journal:  JAMA       Date:  2011-07-20       Impact factor: 56.272

Review 6.  Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.

Authors:  Joel G Winner; Bryan Dechairo
Journal:  Yale J Biol Med       Date:  2015-11-24

Review 7.  Effect of Pharmacogenetic-Based Decision Support Tools in Improving Depression Outcomes: A Systematic Review.

Authors:  Shimaa Aboelbaha; Monica Zolezzi; Hazem Elewa
Journal:  Neuropsychiatr Dis Treat       Date:  2021-07-21       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.